Council for europe portal
Language : en Search
Choose language

Newsroom

Products and Services | News | 15 December 2017 | Strasbourg, France
The 9.5 supplement of European Pharmacopoeia is now available and will be applicable in 38 European countries as from 01 July 2018.
European Pharmacopoeia / Monograph | News | 14 December 2017 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission has achieved an important milestone in the field of biotherapeutic products at its 159th Session, held in Strasbourg on 21-22 November 2017, with the adoption of the monograph for Infliximab concentrated solution (2928).
European Pharmacopoeia / Animal testing | News | 08 December 2017 | Strasbourg, France
During its 159th plenary session, held in Strasbourg on 21-22 November 2017, the European Pharmacopoeia Commission endorsed the complete suppression of the test for abnormal toxicity from the European Pharmacopoeia (Ph. Eur.).
European Pharmacopoeia / Ph. Eur. Commission | News | 07 December 2017 | Strasbourg, France
The EDQM wishes to inform stakeholders that the monograph for Etanercept (2895) will be published in the Supplement 9.5 of the European Pharmacopoeia and will become effective on 1 July 2018.
European Pharmacopoeia / Ph. Eur. Commission | News | 28 November 2017 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission adopted 11 new monographs at its 159th Session, which took place in Strasbourg on 21-22 November 2017.
European Pharmacopoeia / General text/chapter | News | 24 November 2017 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission is consulting its stakeholders on the new version of this major general method which has undergone extensive revision.
Products and Services | News | 07 November 2017 | Strasbourg, France
The EDQM will be closed from 22 December until 2 January 2018. Please find here the deadlines for placing orders to be dispatched in 2017.
European Pharmacopoeia / Pharmacopoeial discussion group (PDG) | News | 26 October 2017 | Strasbourg, France
The meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph.Eur.), Japanese Pharmacopoeia (JP), and the United States Pharmacopoeia (USP)] was hosted by USP in Rockville, Maryland, U.S.A., September 12-13 2017.
European Pharmacopoeia / Alternative method | News | 20 October 2017 | Strasbourg, France
Microbiological control symposium: consensus on readiness of new methods emerges A symposium on microbiology in the pharmaceutical sector was the opportunity for the EDQM to gather feedback from users of the European Pharmacopoeia on alternative testing methods for microbiological control and sterilisation processes.
Products and Services | News | 02 October 2017 | Strasbourg, France
Pharmeuropa contains draft pharmacopoeial texts for which the European Pharmacopoeia Commission is seeking comment.
European Pharmacopoeia | News | 21 September 2017 | Strasbourg, France
With a view to improving the correspondence between liquid chromatography column brand names and the reagents used to describe the stationary phases used with these columns, an overall review of all the monographs concerned has been undertaken.
Certification of suitability (CEP) | News | 06 September 2017 | Strasbourg, France
In October, the EDQM will be present at CPhI Worldwide in Frankfurt (Germany). At this yearly gathering of the pharmaceutical industry, the EDQM is looking forward to meeting as many of its clients as possible.
European Pharmacopoeia / International harmonisation | News | 04 September 2017 | Brasília, Brazil
The European Directorate for the Quality of Medicines and HealthCare (EDQM) and ANVISA, the Health Surveillance Agency of Brazil, today announced the signing of a Memorandum of Understanding (MOU) on their intention to strengthen relations and promote further co-operation in the field of medicines’ quality and science-based pharmacopoeial standards.
European Pharmacopoeia / Pharmacopoeial harmonisation | News | 04 September 2017 | Strasbourg, France
The European Directorate for the Quality of Medicines and HealthCare (EDQM) and the Chinese Pharmacopoeia Commission (ChP) today announced the signing of a new Memorandum of Understanding (MOU) for the next four years.
Products and Services | News | 03 July 2017 | Strasbourg, France
Pharmeuropa contains draft pharmacopoeial texts for which the European Pharmacopoeia Commission is seeking comment.